Treatment Patterns and Health Outcomes in Platinum-Refractory or Platinum-Resistant Ovarian Cancer: A Retrospective Medical Record Review
Conclusions
Current treatments for PRROC yield limited PFS and frequent hospitalizations reported to be related to toxicities or procedural complications, suggesting a continued unmet need for more effective and tolerable therapeutic strategies for PRROC.
Source: International Journal of Gynecological Cancer - Category: Cancer & Oncology Tags: Ovarian Cancer Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | Epithelial Cancer | Fallopian Tube Cancer | Health Management | Ovarian Cancer | Ovaries | Peritoneal Cancer | Toxicology | UK Health | USA Health | Women